An observational study in Prediction of Sepsis in Critical Patients, sponsored by Ruijin Hospital. Status unknown at 1 site in China. Open to participants aged 14 Years and older. Per ClinicalTrials.gov, last updated 2021-10-22.
Sponsored by Ruijin Hospital · Observational
Sepsis is a vital issue in critical care medicine, and early detection and intervention are key to survival. We aimed to establish an early warning system for sepsis based on a data integration platform that can be implemented in the ICU.
1,894 studies on the registry are indexed under Sepsis; 458 are open to participants now.
This study's planned enrollment of 400 is above the median of 160 across 929 observational studies indexed under Sepsis.
Browse Sepsis studies →Ruijin Hospital is the lead sponsor of 635 studies on the registry; 359 are open to participants now.
Counted across the registry records on this site, refreshed daily.
patients that were admitted into the ICU.
Patients who met all of the following criteria were included in the case group:
Exclusion Criteria:
Patients meeting all of the following criteria were included in the control group:
Other: no intervention
Other: no intervention
no intervention
confidence index of sepsis occurrence
Time frame: sepsis occurrence in five hours
This study is status unknown, as verified in Oct 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ruijin Hospital